Annual D&A
$139.70 K
+$81.60 K+140.45%
December 1, 2023
Summary
- As of February 7, 2025, XRTX annual depreciation & amortization is $139.70 thousand, with the most recent change of +$81.60 thousand (+140.45%) on December 1, 2023.
- During the last 3 years, XRTX annual D&A has risen by +$123.70 thousand (+773.12%).
- XRTX annual D&A is now at all-time high.
Performance
XRTX Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$25.90 K
-$7100.00-21.52%
September 1, 2024
Summary
- As of February 7, 2025, XRTX quarterly depreciation & amortization is $25.90 thousand, with the most recent change of -$7100.00 (-21.52%) on September 1, 2024.
- Over the past year, XRTX quarterly D&A has increased by +$1500.00 (+6.15%).
- XRTX quarterly D&A is now -61.23% below its all-time high of $66.80 thousand, reached on March 31, 2023.
Performance
XRTX Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$115.40 K
+$9400.00+8.87%
September 1, 2024
Summary
- As of February 7, 2025, XRTX TTM depreciation & amortization is $115.40 thousand, with the most recent change of +$9400.00 (+8.87%) on September 1, 2024.
- Over the past year, XRTX TTM D&A has dropped by -$24.30 thousand (-17.39%).
- XRTX TTM D&A is now -19.58% below its all-time high of $143.50 thousand, reached on June 1, 2023.
Performance
XRTX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
XRTX Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +140.4% | +6.2% | -17.4% |
| 3 y3 years | +773.1% | -61.2% | -4.9% |
| 5 y5 years | +883.8% | -61.2% | -4.9% |
XRTX Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +876.9% | -61.2% | +581.6% | -19.6% | +701.4% |
| 5 y | 5-year | at high | +876.9% | -61.2% | +661.8% | -19.6% | +701.4% |
| alltime | all time | at high | +1074.0% | -61.2% | +763.3% | -19.6% | +3622.6% |
XORTX Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $25.90 K(-21.5%) | $115.40 K(+8.9%) |
| Jun 2024 | - | $33.00 K(+2.8%) | $106.00 K(+1.0%) |
| Mar 2024 | - | $32.10 K(+31.6%) | $105.00 K(-24.8%) |
| Dec 2023 | $139.70 K(+140.4%) | $24.40 K(+47.9%) | $139.70 K(+1.3%) |
| Sep 2023 | - | $16.50 K(-48.4%) | $137.90 K(-3.9%) |
| Jun 2023 | - | $32.00 K(-52.1%) | $143.50 K(+18.3%) |
| Mar 2023 | - | $66.80 K(+195.6%) | $121.30 K(+108.1%) |
| Dec 2022 | $58.10 K(+306.3%) | $22.60 K(+2.3%) | $58.30 K(+46.9%) |
| Sep 2022 | - | $22.10 K(+125.5%) | $39.70 K(+89.0%) |
| Jun 2022 | - | $9800.00(+157.9%) | $21.00 K(+41.9%) |
| Mar 2022 | - | $3800.00(-5.0%) | $14.80 K(+2.8%) |
| Dec 2021 | $14.30 K | - | - |
| Dec 2021 | - | $4000.00(+17.6%) | $14.40 K(-4.0%) |
| Sep 2021 | - | $3400.00(-5.6%) | $15.00 K(-3.8%) |
| Jun 2021 | - | $3600.00(+5.9%) | $15.60 K(-1.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | $3400.00(-26.1%) | $15.90 K(-1.2%) |
| Dec 2020 | $16.00 K(+5.3%) | $4600.00(+15.0%) | $16.10 K(+3.9%) |
| Sep 2020 | - | $4000.00(+2.6%) | $15.50 K(+2.0%) |
| Jun 2020 | - | $3900.00(+8.3%) | $15.20 K(+0.7%) |
| Mar 2020 | - | $3600.00(-10.0%) | $15.10 K(-0.7%) |
| Dec 2019 | $15.20 K(+7.0%) | $4000.00(+8.1%) | $15.20 K(+7.0%) |
| Sep 2019 | - | $3700.00(-2.6%) | $14.20 K(-1.4%) |
| Jun 2019 | - | $3800.00(+2.7%) | $14.40 K(+1.4%) |
| Mar 2019 | - | $3700.00(+23.3%) | $14.20 K(0.0%) |
| Dec 2018 | $14.20 K(+6.8%) | $3000.00(-23.1%) | $14.20 K(+26.8%) |
| Sep 2018 | - | $3900.00(+8.3%) | $11.20 K(+53.4%) |
| Jun 2018 | - | $3600.00(-2.7%) | $7300.00(+97.3%) |
| Mar 2018 | - | $3700.00(+19.4%) | $3700.00(+19.4%) |
| Dec 2017 | $13.30 K(+11.8%) | - | - |
| Mar 2017 | - | $3100.00 | $3100.00 |
| Dec 2016 | $11.90 K | - | - |
FAQ
- What is XORTX Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for XORTX Therapeutics?
- What is XORTX Therapeutics annual D&A year-on-year change?
- What is XORTX Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for XORTX Therapeutics?
- What is XORTX Therapeutics quarterly D&A year-on-year change?
- What is XORTX Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for XORTX Therapeutics?
- What is XORTX Therapeutics TTM D&A year-on-year change?
What is XORTX Therapeutics annual depreciation & amortization?
The current annual D&A of XRTX is $139.70 K
What is the all time high annual D&A for XORTX Therapeutics?
XORTX Therapeutics all-time high annual depreciation & amortization is $139.70 K
What is XORTX Therapeutics annual D&A year-on-year change?
Over the past year, XRTX annual depreciation & amortization has changed by +$81.60 K (+140.45%)
What is XORTX Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of XRTX is $25.90 K
What is the all time high quarterly D&A for XORTX Therapeutics?
XORTX Therapeutics all-time high quarterly depreciation & amortization is $66.80 K
What is XORTX Therapeutics quarterly D&A year-on-year change?
Over the past year, XRTX quarterly depreciation & amortization has changed by +$1500.00 (+6.15%)
What is XORTX Therapeutics TTM depreciation & amortization?
The current TTM D&A of XRTX is $115.40 K
What is the all time high TTM D&A for XORTX Therapeutics?
XORTX Therapeutics all-time high TTM depreciation & amortization is $143.50 K
What is XORTX Therapeutics TTM D&A year-on-year change?
Over the past year, XRTX TTM depreciation & amortization has changed by -$24.30 K (-17.39%)